Reassessment of Anti-CD20 Therapy in Lymphoid Malignancies: Impact, Limitations, and New Directions

Oncology (Williston Park, N.Y.)

Volumn 31, Issue 5, 2017, Pages 402-411

  Reagan, Patrick M ^a   Friedberg, Jonathan W ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD20 ANTIGEN; MONOCLONAL ANTIBODY; OBINUTUZUMAB; OFATUMUMAB;

B CELL LYMPHOMA; CHRONIC LYMPHATIC LEUKEMIA; HUMAN; IMMUNOLOGY;

ANTIBODIES, MONOCLONAL; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTIGENS, CD20; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LYMPHOMA, B-CELL;

EID: 85030839288     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (0)